Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myelomaRAJE, N; HIDESHIMA, T; KIZILTEPE, T et al.Leukemia. 2009, Vol 23, Num 5, pp 961-970, issn 0887-6924, 10 p.Article

A novel Bcl-2/Bcl-X_L/Bcl-W inhibitor ABT-737 as therapy in multiple myelomaCHAUHAN, D; VELANKAR, M; ANDERSON, K. C et al.Oncogene (Basingstoke). 2007, Vol 26, Num 16, pp 2374-2380, issn 0950-9232, 7 p.Article

Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathwayYASUI, H; HIDESHIMA, T; CHAUHAN, D et al.Leukemia. 2007, Vol 21, Num 3, pp 535-540, issn 0887-6924, 6 p.Article

Bone marrow microenvironment and the identification of new targets for myeloma therapyPODAR, K; CHAUHAN, D; ANDERSON, K. C et al.Leukemia. 2008, issn 0887-6924, R131-R145, NSArticle

Bone marrow microenvironment and the identification of new targets for myeloma therapyPODAR, K; CHAUHAN, D; ANDERSON, K. C et al.Leukemia. 2009, Vol 23, Num 1, pp 10-24, issn 0887-6924, 15 p.Article

A pivotal role for Mcl-1 in Bortezomib-induced apoptosisPODAR, K; GOUILL, S. L; ANDERSON, K. C et al.Oncogene (Basingstoke). 2008, Vol 27, Num 6, pp 721-731, issn 0950-9232, 11 p.Article

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applicationsGUPTA, D; TREON, S. P; SCHLOSSMAN, R. L et al.Leukemia. 2001, Vol 15, Num 12, pp 1950-1961, issn 0887-6924Conference Paper